Cargando…

BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum

Pilocytic astrocytomas (PAs) are increasingly tested for KIAA1549-BRAF fusions. We used reverse transcription polymerase chain reaction for the 3 most common KIAA1549-BRAF fusions, together with BRAF V600E and histone H3.3 K27M analyses to identify relationships of these molecular characteristics wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faulkner, Claire, Ellis, Hayley Patricia, Shaw, Abigail, Penman, Catherine, Palmer, Abigail, Wragg, Christopher, Greenslade, Mark, Haynes, Harry Russell, Williams, Hannah, Lowis, Stephen, White, Paul, Williams, Maggie, Capper, David, Kurian, Kathreena Mary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association of Neuropathologists 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554227/ https://www.ncbi.nlm.nih.gov/pubmed/26222501 http://dx.doi.org/10.1097/NEN.0000000000000226

Ejemplares similares

LGG-53. Evaluation of KIAA-BRAF1549 fusions in pilocytic astrocytoma with clinicopathological correlation
por: Dandapath, Iman, et al.
Publicado: (2022)

Detection of the KIAA1549-BRAF fusion gene in cells forming microvascular proliferations in pilocytic astrocytoma
por: Yamashita, Shinji, et al.
Publicado: (2019)

KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas
por: Becker, Aline Paixão, et al.
Publicado: (2015)

LGG-54. DETECTION OF THE KIAA1549-BRAF FUSION GENE IN CELLS FORMING MICROVASCULAR PROLIFERATIONS IN PILOCYTIC ASTROCYTOMA
por: Yamashita, Shinji, et al.
Publicado: (2020)

Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing
por: Selt, Florian, et al.
Publicado: (2016)

Incidence of kiaa1549-braf fusion gene in Egyptian pediatric low grade glioma
por: Taha, Hala, et al.
Publicado: (2015)

A novel GIT2-BRAF fusion in pilocytic astrocytoma
por: Helgager, Jeffrey, et al.
Publicado: (2017)

An optimized workflow to improve reliability of detection of KIAA1549:BRAF fusions from RNA sequencing data
por: Sommerkamp, Alexander C., et al.
Publicado: (2020)

LGG-13. PILOCYTIC ASTROCYTOMAS WITH NOVEL BRAF FUSIONS DEMONSTRATE MAPK PATHWAY ACTIVATION
por: Chatwin, Hannah, et al.
Publicado: (2021)

LGG-07. Novel CRISPR/Cas9 induced KIAA1549:BRAF fusion model for preclinical studies of pediatric gliomas
por: Patel, Krupesh, et al.
Publicado: (2022)

Generation of patient-derived models from a metastatic pediatric diffuse leptomeningeal glioneuronal tumor with KIAA1549::BRAF fusion
por: Messiaen, Julie, et al.
Publicado: (2022)

Novel BRAF Alteration in a Sporadic Pilocytic Astrocytoma
por: Dahiya, Sonika, et al.
Publicado: (2012)

A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma
por: Tomić, Tajana Tešan, et al.
Publicado: (2017)

In silico analysis identifies a putative cell-of-origin for BRAF fusion-positive cerebellar pilocytic astrocytoma
por: Younes, Subhi Talal, et al.
Publicado: (2020)

Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas
por: Penman, Catherine Louise, et al.
Publicado: (2015)

Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein
por: Subbiah, Vivek, et al.
Publicado: (2014)

Durable Response of Dabrafenib, Trametinib, and Capmatinib in an NSCLC Patient With Co-Existing BRAF-KIAA1549 Fusion and MET Amplification: A Case Report
por: Chou, Yun-Tse, et al.
Publicado: (2022)

Correction: A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma
por: Tomić, Tajana Tešan, et al.
Publicado: (2017)

Detection and genomic analysis of BRAF fusions in Juvenile Pilocytic Astrocytoma through the combination and integration of multi-omic data
por: Zwaig, Melissa, et al.
Publicado: (2022)

TBIO-09. IN SILICO ANALYSIS IDENTIFIES A PUTATIVE CELL-OF-ORIGIN FOR BRAF FUSION-POSITIVE CEREBELLAR PILOCYTIC ASTROCYTOMA
por: Younes, Subhi Talal
Publicado: (2020)

Spindle cell sarcoma with KIAA1549-BRAF resembling infantile fibrosarcoma morphologically: A case report and literature review
por: Fujikawa, Tomoko, et al.
Publicado: (2022)

LGG-03. EXPLORING THE SIGNALING NETWORK INVOLVED IN MAPK PATHWAY INHIBITION BY THE MEK INHIBITOR TRAMETINIB IN BRAF-FUSION-DRIVEN PEDIATRIC PILOCYTIC ASTROCYTOMA
por: Sigaud, Romain, et al.
Publicado: (2023)

KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production
por: Chen, Ran, et al.
Publicado: (2018)

LINC-25. BRAF ABERRATIONS IN PEDIATRIC PILOCYTIC ASTROCYTOMAS (PCAs): PREVALENCE AND IMPACT ON CLINICAL OUTCOME
por: Ramanathan, Subramaniam, et al.
Publicado: (2020)

LGG-27. Molecular implications of mitogen-activated protein kinase pathway inhibition by the MEK inhibitor trametinib in BRAF-fusion-driven pediatric pilocytic astrocytoma
por: Sigaud, Romain, et al.
Publicado: (2022)

LGG-07. IS BRAF ALTERATION OR A HISTOLOGIC ‘QUALIFIER’ A PREDICTOR OF OUTCOME IN PEDIATRIC PILOCYTIC ASTROCYTOMA?
por: Cler, Samuel J, et al.
Publicado: (2021)

Spontaneous Malignant Transformation of a Pilocytic Astrocytoma of Cerebellum: Case Report
por: Coelho, Joana, et al.
Publicado: (2015)

LGG-06. Selumetinib in pediatric patients with non-neurofibromatosis type 1-associated, non-optic pathway (OPG) and non-pilocytic recurrent/progressive low-grade glioma harboring BRAFV600E mutation or BRAF-KIAA1549 fusion: a multicenter prospective Pediatric Brain Tumor Consortium (PBTC) Phase 2 trial
por: Fangusaro, Jason, et al.
Publicado: (2022)

Detection of BRAF V600E Mutation in Ganglioglioma and Pilocytic Astrocytoma by Immunohistochemistry and Real-Time PCR-Based Idylla Test
por: Durślewicz, Justyna, et al.
Publicado: (2020)

LGG-23. EXCELLENT CLINICAL / RADIOLOGICAL RESPONSE TO BRAF INHIBITION IN A YOUNG CHILD WITH IN-OPERABLE SUPRA-SELLAR PILOCYTIC ASTROCYTOMA
por: Chapman, Stacy, et al.
Publicado: (2020)

LGG-48. PROLIFIC GROWTH OF BRAF V600E MUTANT PILOCYTIC ASTROCYTOMA WHILE ON KETOGENIC DIET: CASE REPORT
por: Batchelder, Patti, et al.
Publicado: (2020)

PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia
por: Anderl, Stefanie, et al.
Publicado: (2015)

Children with supratentorial midline pilocytic astrocytomas exhibit multiple progressions and acquisition of neurologic deficits over time
por: Brossier, Nicole M, et al.
Publicado: (2021)

Recurrent somatic BRAF insertion (p.V504_R506dup): a tumor marker and a potential therapeutic target in pilocytic astrocytoma
por: Khater, Fida, et al.
Publicado: (2018)

Activation of the Hedgehog pathway in pilocytic astrocytomas
por: Rush, Sarah Z., et al.
Publicado: (2010)

MAPK pathway activation in pilocytic astrocytoma
por: Jones, David T. W., et al.
Publicado: (2011)

Spinal hemangioblastoma combined with pilocytic astrocytoma
por: Li, Wei-Qing, et al.
Publicado: (2015)

The age of adult pilocytic astrocytoma cells
por: Voronina, Natalia, et al.
Publicado: (2021)

Erratum to “KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production” [Neoplasia, Volume: 21, Issue:1, (2019) 52–60]
por: Chen, Ran, et al.
Publicado: (2020)

Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas
por: Valera, Elvis Terci, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i32b1tdoekk7ppl4p4tu1djsq3